v3.26.1
Loss per share - Additional Information (Detail)
 12 Months Ended
May 28, 2024
$ / shares
Dec. 31, 2025
shares
$ / shares
Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]    
Number of share options exercisable in share-based payment arrangement   75,000
Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise | $ / shares   $ 16
Weighted average share price | $ / shares $ 16  
Warrants [member]    
Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]    
Dilutive effect of warrants on weighted average number of ordinary shares   18,650,000
Weighted average share price | $ / shares   $ 2.36
Deferred Share Units [Member]    
Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]    
Number of share option vested in share based payment arrangement   2,921,917
Restricted share units [member]    
Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]    
Number of share option vested in share based payment arrangement   3,664,750